DK200000687A - Middel til forsøgelse af afgivelsen af cerebral acetylcholin - Google Patents

Middel til forsøgelse af afgivelsen af cerebral acetylcholin Download PDF

Info

Publication number
DK200000687A
DK200000687A DK200000687A DKPA200000687A DK200000687A DK 200000687 A DK200000687 A DK 200000687A DK 200000687 A DK200000687 A DK 200000687A DK PA200000687 A DKPA200000687 A DK PA200000687A DK 200000687 A DK200000687 A DK 200000687A
Authority
DK
Denmark
Prior art keywords
delivery
attempting
agent
cerebral acetylcholine
cerebral
Prior art date
Application number
DK200000687A
Other languages
Danish (da)
English (en)
Inventor
Nakamura Kazuo
Shirane Masatoshi
Tanaka Yushiro
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK200000687A publication Critical patent/DK200000687A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK200000687A 1999-04-27 2000-04-25 Middel til forsøgelse af afgivelsen af cerebral acetylcholin DK200000687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99108223 1999-04-27

Publications (1)

Publication Number Publication Date
DK200000687A true DK200000687A (da) 2000-10-28

Family

ID=8238054

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200000687A DK200000687A (da) 1999-04-27 2000-04-25 Middel til forsøgelse af afgivelsen af cerebral acetylcholin

Country Status (24)

Country Link
US (1) US20030073744A1 (fr)
JP (1) JP2000309529A (fr)
KR (1) KR100372906B1 (fr)
CN (1) CN1277019A (fr)
AR (1) AR023763A1 (fr)
AT (1) AT408836B (fr)
AU (1) AU3011300A (fr)
BE (1) BE1013314A3 (fr)
BR (1) BR0002381A (fr)
CA (1) CA2307022A1 (fr)
DE (1) DE10020237A1 (fr)
DK (1) DK200000687A (fr)
ES (1) ES2176078A1 (fr)
FI (1) FI20000977A7 (fr)
FR (1) FR2792833B1 (fr)
GB (1) GB2351662A (fr)
GR (1) GR1003591B (fr)
IE (1) IE20000308A1 (fr)
IT (1) IT1318490B1 (fr)
NL (1) NL1015043C2 (fr)
PT (1) PT102456B (fr)
SE (1) SE0001499L (fr)
TR (1) TR200001133A2 (fr)
ZA (1) ZA200002041B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5273731B2 (ja) * 2009-08-11 2013-08-28 独立行政法人産業技術総合研究所 生体リズムの制御剤
CA3119517C (fr) * 2018-11-13 2023-08-22 Xianfeng PENG Application d'un derive acyle d'acide amine dans la preparation d'un additif alimentaire pour animaux

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
JPH1081607A (ja) * 1996-09-06 1998-03-31 Kamiyama:Kk 抗菌剤
JPH1081626A (ja) * 1996-09-06 1998-03-31 Kamiyama:Kk チロシナーゼ活性阻害剤

Also Published As

Publication number Publication date
ZA200002041B (en) 2000-10-27
FI20000977L (fi) 2000-10-27
FR2792833A1 (fr) 2000-11-03
ATA7162000A (de) 2001-08-15
NL1015043A1 (nl) 2000-10-30
JP2000309529A (ja) 2000-11-07
NL1015043C2 (nl) 2001-03-30
CN1277019A (zh) 2000-12-20
ES2176078A1 (es) 2002-11-16
IT1318490B1 (it) 2003-08-25
ITMI20000914A0 (it) 2000-04-21
AR023763A1 (es) 2002-09-04
PT102456A (pt) 2000-11-30
AT408836B (de) 2002-03-25
GR1003591B (el) 2001-05-22
IE20000308A1 (en) 2000-11-29
ITMI20000914A1 (it) 2001-10-21
FI20000977A7 (fi) 2000-10-27
TR200001133A2 (tr) 2000-11-21
GB2351662A (en) 2001-01-10
FI20000977A0 (fi) 2000-04-26
BE1013314A3 (fr) 2001-11-06
GB0010049D0 (en) 2000-06-14
KR20010029658A (ko) 2001-04-06
SE0001499D0 (sv) 2000-04-26
FR2792833B1 (fr) 2002-09-06
SE0001499L (sv) 2000-10-28
US20030073744A1 (en) 2003-04-17
DE10020237A1 (de) 2001-02-08
GR20000100145A (el) 2000-12-29
PT102456B (pt) 2003-04-30
BR0002381A (pt) 2000-11-07
AU3011300A (en) 2000-11-02
KR100372906B1 (ko) 2003-02-17
CA2307022A1 (fr) 2000-10-27

Similar Documents

Publication Publication Date Title
JP2002522485A5 (fr)
JP2002532392A5 (fr)
WO2005065069A3 (fr) Procedes pharmaceutiques, posologies et formes posologiques pour le traitement de la maladie d'alzheimer
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
ATE146677T1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
RU2009123536A (ru) Стабильные парентеральные составы, включающие ингибиторы pcb на основе бензодиазепина
JPS59193821A (ja) 抗不安薬としてのフルオキセチンの使用法
SK7532002A3 (en) Pharmaceutical formulations containing zolmitriptan
BE900749A (fr) Medicament microencapsule dans une matrice sucree.
RU2002122084A (ru) Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных растройств
CH670763A5 (fr)
US20150352038A1 (en) A dosage form for administering an active principle for accelerated sleep induction and/or for treating sleep disorders and/or for treating a central nervous system disorder
JP2002540148A5 (fr)
DK200000687A (da) Middel til forsøgelse af afgivelsen af cerebral acetylcholin
ATE192926T1 (de) Flavopereirine enthaltende zusammensetzung und ihre anwendung in der behandlung gegen hiv-viren
KR860003018A (ko) 1-β-D-리보푸라노실-1,2,4-트리아졸-3-카르복사미드를 이용한 인체의 비루스성 질환의 의학적 치료방법
KR890004705A (ko) 항바이러스성 제제
AR006202A1 (es) Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene
JP2023520703A5 (fr)
DE69803670D1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
EP0402208B1 (fr) Association de vitamine A à dose physiologique et de différents principes actifs ayant une activité thérapeutique
JP2003523385A5 (fr)
DE50010973D1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
ES2287512T3 (es) Utilizacion combinada de metilfenidato y melatonina para el tratamiento de la enfermedad de hiperactividad con deficit de atencion.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment